Transforming healthcare

with innovative extrahepatic

RNA delivery

About us

Pioneering Extrahepatic RNA delivery

Starna Therapeutics was founded in August 2021, focusing on extrahepatic targeted delivery technology. The company is dedicated to developing innovative RNA-based drugs to address unmet clinical needs. With the expertise in nucleic acid drug discovery, delivery technology, and process development, we have established a robust industrial chain encompassing chemistry, mRNA, and LNP preparations.

Leveraging our propretary STAR(Selective Targeted RNA Delivery) LNP technology platform, we are capable of delivering a diverse range of RNA-based modalities to specific organs and tissues, and more importantly, to individual cell types, like T cells. This comprehensive approach enables us to accurtely target delivery medicines and overcome the core challenges in RNA drug research and development.

Mission vision value


Using RNA
to benefit life and health


To be a leader
in innovative RNA medicines


Respect and cooperation
Realistic and innovative
Pursuit of Excellence

Technology and Platforms